scholarly article | Q13442814 |
P2093 | author name string | Salles B | |
Calsou P | |||
Frit P | |||
P2860 | cites work | Proliferating cell nuclear antigen is required for DNA excision repair | Q28182009 |
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines | Q36698590 | ||
Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimer | Q36968114 | ||
How Relevant is the Escherichia coli UvrABC Model for Excision Repair in Eukaryotes? | Q37043242 | ||
Nucleotide excision repair in Escherichia coli | Q37056044 | ||
Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position | Q37404894 | ||
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. | Q37422551 | ||
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). | Q37523234 | ||
Molecular genetics of eukaryotic DNA excision repair | Q38028472 | ||
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin | Q38329454 | ||
Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin | Q38340395 | ||
Substrate overlap and functional competition between human nucleotide excision repair and Escherichia coli photolyase and (a)BC excision nuclease | Q38340400 | ||
Mechanisms of cellular resistance to cisplatin | Q39519222 | ||
Resistance to cisplatin and analogues: mechanisms and potential clinical implications | Q39525356 | ||
Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract. | Q40450557 | ||
Removal of psoralen monoadducts and crosslinks by human cell free extracts | Q40506521 | ||
Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free system | Q40513521 | ||
RecA-dependent incision of psoralen-crosslinked DNA by (A)BC excinuclease | Q40531236 | ||
Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II). | Q40538207 | ||
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication | Q41202176 | ||
Cyclobutane dimers and (6-4) photoproducts in human cells are mended with the same patch sizes | Q41667312 | ||
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells | Q41687395 | ||
Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion. | Q41757759 | ||
Repair of pyrimidine dimer ultraviolet light photoproducts by human cell extracts | Q42159727 | ||
Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. | Q43484172 | ||
DNA excision repair in cell extracts from human cell lines exhibiting hypersensitivity to DNA-damaging agents | Q44551787 | ||
An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and "second-arm" crosslink reactions | Q44756839 | ||
Conversion of monofunctional DNA adducts of cis-diamminedichloroplatinum (II) to bifunctional lesions. Effect on the in vitro replication of single-stranded DNA by Escherichia coli DNA polymerase I and eukaryotic DNA polymerases alpha. | Q52454449 | ||
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). | Q52832659 | ||
Role of carrier ligand in platinum resistance in L1210 cells. | Q54313675 | ||
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality. | Q54332081 | ||
Interaction of the UvrABC endonuclease with DNA containing a psoralen monoadduct or cross-link. Differential effects of superhelical density and comparison of preincision complexes | Q54687234 | ||
In vitro repair of psoralen-DNA cross-links by RecA, UvrABC, and the 5'-exonuclease of DNA polymerase I. | Q54731105 | ||
Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. | Q55060652 | ||
Effect of exogenous DNA fragments on human cell extract-mediated DNA repair synthesis | Q60311339 | ||
Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin | Q64390050 | ||
Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II) | Q68097905 | ||
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines | Q68343885 | ||
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA | Q69586643 | ||
Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II) | Q69959332 | ||
In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication | Q70126283 | ||
Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity | Q70791156 | ||
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells | Q71230607 | ||
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation | Q93607580 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6363-6368 | |
P577 | publication date | 1992-12-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts | |
P478 | volume | 20 |
Q36460000 | Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA Adducts |
Q41702067 | Cisplatin resistance and DNA repair |
Q33601030 | DNA damage excision repair in microplate wells with chemiluminescence detection: development and perspectives. |
Q34725611 | DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. |
Q38348382 | DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes |
Q43955963 | Deregulated DNA polymerase beta strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities |
Q70721567 | Detection of minor adducts in cisplatin-modified DNA by transcription footprinting |
Q34625375 | Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts |
Q54649579 | Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA. |
Q40951206 | Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line |
Q38340847 | High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA. |
Q45770163 | In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic |
Q34282241 | Mechanisms of resistance to cisplatin |
Q34866688 | Molecular aspects of resistance to antitumor platinum drugs. |
Q40400417 | Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene |
Q41886077 | Recognition of DNA alterations by the mismatch repair system |
Q35009287 | Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage |
Q41434234 | Structural studies of interactions between anticancer platinum drugs and DNA. |
Search more.